Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these matters, substantial doubt exists about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”View the 10-Q filed Aug 10, 2026
Earnings call · FY2025 Q4
Executive readout · one minute
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
From the 8-K filed Mar 26, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Medical Margin
table
Year Ending December 31, 2026
|
$160M – $200M | Non-GAAP | |
|
Total Revenues
table
Year Ending December 31, 2026
|
$1.5B – $1.7B | — | |
|
Medical Margin PMPM
table
Year Ending December 31, 2026
|
$120 – $150 | Non-GAAP | |
|
Adjusted EBITDA
table
Year Ending December 31, 2026
|
$-20M – $40M | Non-GAAP |
SEC filing · Item 2.02
Filed Mar 26, 2026 · complete as-filed document
SEC periodic report
Filed Mar 26, 2026 · complete as-filed document